Changing patterns of relapse in Hodgkin's disease

Area of Science:

• Oncology
• Clinical Medicine

Background:

• Early and late relapses are critical concerns in Hodgkin's disease management.
• Improved staging and treatment have reduced early relapses but not late relapses.

Purpose of the Study:

• To identify predictors of late relapse in stage I and II Hodgkin's disease.
• To inform long-term follow-up strategies for patients in remission.

Main Methods:

• Retrospective analysis of 432 patients with stage I/II Hodgkin's disease treated between 1964-1983.
• Comparison of relapse patterns based on treatment modality, staging, and clinical presentation.

Main Results:

• Late relapse risk did not decrease with improved treatments.
• Radiotherapy alone was associated with a higher incidence of late relapse compared to combined modality therapy (P<0.05).
• Stage II disease and absence of B symptoms were linked to increased late relapse risk.

Conclusions:

• Patients with stage I/II Hodgkin's disease, particularly those treated with radiotherapy or with stage II disease/no B symptoms, face a persistent risk of late relapse.
• Continued close follow-up beyond 3 years is crucial for monitoring these high-risk patients.